Sanofi Debt-to-Equity Ratio Growth & History (SAN)

Sanofi's debt-to-equity ratio was 0.28 for fiscal 2025.

View full Sanofi company overview

Sanofi annual debt-to-equity ratio history

Sanofi annual debt-to-equity ratio

Fiscal yearPeriod endedDebt-to-equity ratioChangeGrowth
20252025-12-310.280.05+23.28%
20242024-12-310.23−0.02−7.15%
20232023-12-310.25−0.03−12.28%
20222022-12-310.28−0.04−13.09%
20212021-12-310.33−0.05−13.01%
20202020-12-310.38−0.06−14.57%
20192019-12-310.440.02+4.93%
20182018-12-310.420.15+57.12%
20172017-12-310.27−0.06−17.18%
20162016-12-310.320.04+13.85%
20152015-12-310.28

Sanofi debt-to-equity ratio trends

Over the last five fiscal years, Sanofi's debt-to-equity ratio decreased from 0.38 to 0.28, a change of −0.09. The latest reported quarter, Q2 2026, shows 0.34.

About the metric

What the debt-to-equity ratio means

The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.

Calculation and source

How debt-to-equity is calculated

TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Sanofi source filings ↗

Community posts

It’s quiet here.

No posts about SAN yet. Start the conversation.

Write the first post